MedTrace Logo

Early Rehabilitation After Hip Fracture

NCT00133640 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2006-09-11

No results posted yet for this study

Summary

The aim of this study is to compare a low versus high intensity physiotherapy early rehabilitation program combined with a low versus high dose vitamin D early rehabilitation program in a randomized controlled trial among elderly patients with acute hip fracture in an acute care setting. The primary outcome to be compared between treatment arms is the rate of falls during a 12-month follow-up. Secondary outcomes are injurious falls, number of persons who fell, low-trauma fractures (at the hip, forearm, humerus, pelvis, ankle, spine, femur, tibia), disability, quality of life (Euro-Qol), mortality and health care utilization. Another secondary outcome will be admission to nursing home compared between treatment arms among subjects, who are community-dwelling prior to the index hip fracture. Admission to nursing home is the marker of loss of independence for the individual, but also triggers high cost for the society.

The study will provide new early rehabilitation guidelines to allocate health care resources efficiently in the acute care setting. Eventually and most importantly, the study will help improve outcomes in patients with hip fractures.

Conditions

  • Accidental Falls
  • Fractures
  • Hip Fractures

Interventions

DRUG

cholecalciferol

BEHAVIORAL

Physiotherapy

Sponsors & Collaborators

  • Swiss National Science Foundation

    lead OTHER

Principal Investigators

  • Heike A Bischoff-Ferrari, MD, MPH · University of Zurich

  • Robert Theiler, MD · Triemli Spital Zurich

  • Hannes B Staehelin, MD · University of Basel

  • Andreas Platz, MD · TriemliSpital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2008-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00133640 on ClinicalTrials.gov